Moderna, Merck breakthrough could usher in wave of cancer vaccines

Merck and Moderna's success with a personalized cancer vaccine designed to keep melanoma at bay opens a ​new avenue of treatment that doctors hope will work against many types of tumors.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。